Stanford Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,855
Closed -$160K 177
2016
Q4
$160K Hold
2,855
0.08% 59
2016
Q3
$170K Hold
2,855
0.08% 65
2016
Q2
$157K Hold
2,855
0.08% 68
2016
Q1
$144K Hold
2,855
0.08% 69
2015
Q4
$144K Hold
2,855
0.08% 74
2015
Q3
$135K Buy
2,855
+2
+0.1% +$106 0.1% 66
2015
Q2
$155K Sell
2,853
-417
-13% -$23.4K 0.12% 66
2015
Q1
$179K Hold
3,270
0.14% 56
2014
Q4
$177K Buy
+3,270
New +$182K 0.15% 55

Other funds holding MRK

Stanford Investment Group's MRK Position: Q1 2017 in Review

Stanford Investment Group sold out of Merck (MRK) in Q1 2017, closing a stake of 2,855 shares — an estimated $160K sold.

Stanford Investment Group first reported a position in MRK in Q4 2014 and held it in 9 quarters. The position peaked at $179K in Q1 2015. 1,942 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Stanford Investment Group reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 2,855 Merck shares in Q1 2017, an estimated $160K.
  • Stanford Investment Group first reported a position in Merck in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Merck position peaked at $179K in Q1 2015.
  • 1,942 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.